Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2026-01-01 @ 4:49 AM
Study NCT ID:
NCT01428635
Status:
COMPLETED
Last Update Posted:
2023-09-26
First Post:
2011-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | View |
| None | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | View |
| None | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | View |
| None | Primary Myelofibrosis | View |
| None | Thrombocytopenia | View |
Keywords: